Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Schizophrenia

Interventions

DRUG

Roflumilast

Roflumilast tablets

DRUG

Placebo

Roflumilast placebo-matching tablets

DRUG

Second generation antipsychotic

Second Generation Antipsychotic (SGA) medication for standard of care therapy will be sourced and managed locally by the site.

Trial Locations (1)

Denmark Hill